Cited by 3Glutathione Transferases and PolymorphismsArsenic contamination and mitigationRedox biology and oxidative stress

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Proposed mechanism for monomethylarsonate reductase activity of human omega-class glutathione transferase GSTO1-1

Open access
Oakley, Aaron J.·2022·Biochemical and Biophysical Research Communications

Published version of a preprint

Abstract

Contamination of drinking water with toxic inorganic arsenic is a major public health issue. The mechanisms of enzymes and transporters in arsenic elimination are therefore of interest. The human omega-class glutathione transferases have been previously shown to possess monomethylarsonate (V) reductase activity. To further understanding of this activity, molecular dynamics of human GSTO1-1 bound to glutathione with a monomethylarsonate isostere were simulated to reveal putative monomethylarsonate binding sites on the enzyme. The major binding site is in the active site, adjacent to the glutathione binding site. Based on this and previously reported biochemical data, a reaction mechanism for this enzyme is proposed. Further insights were gained from comparison of the human omega-class GSTs to homologs from a range of animals.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbrc.2021.12.072

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 36

  1. Ratnaike, 2003, Acute and chronic arsenic toxicity, Postgrad. Med., 79, 391, 10.1136/pmj.79.933.391 · DOI · Paper page
  2. Aposhian, 1997, Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity, Annu. Rev. Pharmacol. Toxicol., 37, 397, 10.1146/annurev.pharmtox.37.1.397 · DOI
  3. Hayakawa, 2005, A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19, Arch. Toxicol., 79, 183, 10.1007/s00204-004-0620-x · DOI
  4. Khairul, 2017, Metabolism, toxicity and anticancer activities of arsenic compounds, Oncotarget, 8, 23905, 10.18632/oncotarget.14733 · DOI
  5. Zakharyan, 2001, Human monomethylarsonic acid (MMA(V)) reductase is a member of the glutathione-S-transferase superfamily, Chem. Res. Toxicol., 14, 1051, 10.1021/tx010052h · DOI
  6. Oakley, 2011, Glutathione transferases: a structural perspective, Drug Metab. Rev., 43, 138, 10.3109/03602532.2011.558093 · DOI
  7. Chowdhury, 2006, Glutathione-S-transferase-omega [MMA(V) reductase] knockout mice: enzyme and arsenic species concentrations in tissues after arsenate administration, Toxicol. Appl. Pharmacol., 216, 446, 10.1016/j.taap.2006.06.014 · DOI
  8. Whitbread, 2005, Characterization of the omega class of glutathione transferases, Methods Enzymol., 401, 78, 10.1016/S0076-6879(05)01005-0 · DOI
  9. Schmuck, 2005, Characterization of the monomethylarsonate reductase and dehydroascorbate reductase activities of Omega class glutathione transferase variants: implications for arsenic metabolism and the age-at-onset of Alzheimer's and Parkinson's diseases, Pharmacogenetics Genom., 15, 493, 10.1097/01.fpc.0000165725.81559.e3 · DOI
  10. Beebe-Dimmer, 2012, Genetic variation in glutathione S-transferase omega-1, arsenic methyltransferase and methylene-tetrahydrofolate reductase, arsenic exposure and bladder cancer: a case-control study, Environ. Health, 11, 43, 10.1186/1476-069X-11-43 · DOI
  11. Escobar-García, 2012, Arch. Toxicol., 86, 857, 10.1007/s00204-012-0802-x · DOI
  12. Board, 2000, Identification, characterization and crystal structure of the omega class glutathione transferases, J. Biol. Chem., 275, 24798, 10.1074/jbc.M001706200 · DOI
  13. Zhou, 2012, Structural insights into the dehydroascorbate reductase activity of human omega-class glutathione transferases, J. Mol. Biol., 420, 190, 10.1016/j.jmb.2012.04.014 · DOI
  14. Hayes, 2005, Glutathione transferases, Annu. Rev. Pharmacol. Toxicol., 45, 51, 10.1146/annurev.pharmtox.45.120403.095857 · DOI
  15. Atkinson, 2009, Glutathione transferases are structural and functional outliers in the thioredoxin fold, Biochemistry, 48, 11108, 10.1021/bi901180v · DOI
  16. Menon, 2014, Glutathione transferase omega 1 is required for the lipopolysaccharide-stimulated induction of NADPH oxidase 1 and the production of reactive oxygen species in macrophages, Free Radic. Biol. Med., 73, 318, 10.1016/j.freeradbiomed.2014.05.020 · DOI
  17. Hughes, 2019, Glutathione transferase omega-1 regulates NLRP3 inflammasome activation through NEK7 deglutathionylation, Cell Rep., 29, 151, 10.1016/j.celrep.2019.08.072 · DOI
  18. Tsuboi, 2011, Potent and selective inhibitors of glutathione S-transferase omega 1 that impair cancer drug resistance, J. Am. Chem. Soc., 133, 16605, 10.1021/ja2066972 · DOI
  19. Dai, 2019, Structure-based design of N-(5-Phenylthiazol-2-yl)acrylamides as novel and potent glutathione S-transferase omega 1 inhibitors, J. Med. Chem., 62, 3068, 10.1021/acs.jmedchem.8b01960 · DOI
  20. Xie, 2020, Development of benzenesulfonamide derivatives as potent glutathione transferase omega-1 inhibitors, J. Med. Chem., 63, 2894, 10.1021/acs.jmedchem.9b01391 · DOI
  21. Pang, 2014, Low-mass molecular dynamics simulation: a simple and generic technique to enhance configurational sampling, Biochem. Biophys. Res. Commun., 452, 588, 10.1016/j.bbrc.2014.08.119 · DOI
  22. Phillips, 2020, Scalable molecular dynamics on CPU and GPU architectures with NAMD, J. Chem. Phys., 153
  23. Robertson, 2015, Improved peptide and protein torsional energetics with the OPLSAA force field, J. Chem. Theor. Comput., 11, 3499, 10.1021/acs.jctc.5b00356 · DOI
  24. Dodda, 2017, LigParGen web server: an automatic OPLS-AA parameter generator for organic ligands, Nucleic Acids Res., 45, W331, 10.1093/nar/gkx312 · DOI
  25. Humphrey, 1996, VMD: visual molecular dynamics, J. Mol. Graph., 14, 33, 10.1016/0263-7855(96)00018-5 · DOI · Paper page
  26. Larkin, 2007, Clustal W and clustal X version 2.0, Bioinformatics, 23, 2947, 10.1093/bioinformatics/btm404 · DOI
  27. Jurrus, 2018, Improvements to the APBS biomolecular solvation software suite, Protein Sci., 27, 112, 10.1002/pro.3280 · DOI
  28. Saisawang, 2019, Glutathione transferase Omega 1-1 (GSTO1-1) modulates Akt and MEK1/2 signaling in human neuroblastoma cell SH-SY5Y, Proteins, 87, 588, 10.1002/prot.25683 · DOI
  29. Cullen, 1984, The reaction of methylarsenicals with thiols: some biological implications, J. Inorg. Biochem., 21, 179, 10.1016/0162-0134(84)83002-0 · DOI
  30. Brock, 2013, Structural insights into omega-class glutathione transferases: a snapshot of enzyme reduction and identification of a non-catalytic ligandin site, PLoS One, 8, 10.1371/journal.pone.0060324 · DOI
  31. Rosen, 2020, Isofunctional clustering and conformational analysis of the arsenate reductase superfamily reveals nine distinct clusters, Biochemistry, 59, 4262, 10.1021/acs.biochem.0c00651 · DOI
  32. DeMel, 2004, Arginine 60 in the ArsC arsenate reductase of E. coli plasmid R773 determines the chemical nature of the bound As(III) product, Protein Sci., 13, 2330, 10.1110/ps.04787204 · DOI
  33. LoBello, 1997, Multifunctional role of Tyr 108 in the catalytic mechanism of human glutathione transferase P1-1. Crystallographic and kinetic studies on the Y108F mutant enzyme, Biochemistry, 36, 6207, 10.1021/bi962813z · DOI
  34. Ji, 1994, Structure and function of the xenobiotic substrate binding site of a glutathione S-transferase as revealed by X-ray crystallographic analysis of product complexes with the diastereomers of 9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene, Biochemistry, 33, 1043, 10.1021/bi00171a002 · DOI
  35. Chen, 2015, Therapeutic and analytical applications of arsenic binding to proteins, Metallomics, 7, 39, 10.1039/C4MT00222A · DOI
  36. de Thé, 2017, Acute promyelocytic leukemia: a paradigm for oncoprotein-targeted cure, Cancer Cell, 32, 552, 10.1016/j.ccell.2017.10.002 · DOI

Metadata

Authors
Oakley, A. J.
Affiliations
University of Wollongong (AU)
Corresponding author
Oakley, Aaron J.
Venue
Biochemical and Biophysical Research Communications
Publisher
Elsevier BV
Published
2022-01
Volume
590
Pages
7-13
ISSN
0006-291X (ISSN-L)
OpenAlex
W4225861523
Cited by
3
References
2
Citations by year
2025: 2 · 2022: 1
FWCI
0.08
Type
journal article
Language
en
Open access
Locations
  • Biochemical and Biophysical Research Communications (publishedVersion)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Research Online (University of Wollongong) (submittedVersion)
  • Figshare (submittedVersion)
Funders
  • National Health and Medical Research Council (APP1124673, APP1156455)
  • National Institutes of Health (R01-GM129325)
  • National Institute of Allergy and Infectious Diseases
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
  • Physical Sciences › Environmental Science › Environmental Chemistry › Arsenic contamination and mitigation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
Keywords
arsenic detoxification, inorganic arsenic, glutathione binding site, enzyme mechanism, molecular dynamics simulation, active site
MeSH terms
Amino Acid Sequence, Glutathione Transferase, Humans, Models, Molecular, Oxidoreductases, Catalytic Domain

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review